We showed that the estimated levels of CXCL10, CXCL11, enRAGE and CRP were increased in deceased T2D patients, reinforcing the role of subclinical chronic inflammation as a mediator of unfavorable outcomes in T2D. The gene discussed is CXCL11; the disease is type 2 diabetes mellitus.